FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology and concerns treating lung cancer. That is ensured by 6 therapeutic sessions every 21 day according to the scheme: the patient is exposed to hyperbaric oxygenation at pressure 1.3 atm, 30 min daily for 5 days; and then chemotherapeutic preparations are administered as follows: on the 6th day, kemoplat dissolved in 0.9% sodium chloride is administered in a dose of 75 mg/m2 of the patient's body; on the 6th, 8th and 10th days, phytoside 120 mg/m2 of the patient's body dissolved in 0.9% sodium chloride is administered.
EFFECT: dose schedule of the chemopreparations in a combination with the hyperbaric oxygenation provides reducing such side effects of the chemotherapy as leukopenia and anaemia that in turn enables the following sessions of chemotherapy in the prescribed time and thereby increasing the clinical effectiveness in lung cancer.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ONCOLOGICAL PATIENTS WITH LUNG CANCER | 2011 |
|
RU2481091C1 |
METHOD OF TREATMENT OF INOPERABLE SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2023 |
|
RU2806512C1 |
METHOD FOR TREATING MALIGNANT TUMORS OF PENIS | 1996 |
|
RU2139113C1 |
METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
METHOD OF LUNG CANCER TREATMENT | 2014 |
|
RU2554750C1 |
METHOD OF THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER OF IB3-IIIB STAGES | 2022 |
|
RU2799247C2 |
METHOD OF TREATING OPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706347C1 |
METHOD OF TREATING INOPERABLE PANCREATIC ADENOCARCINOMA WITH LIVER METASTASES | 2019 |
|
RU2706786C1 |
METHOD OF TREATING OPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706339C1 |
Authors
Dates
2013-08-27—Published
2011-11-15—Filed